• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs.

作者信息

Doshi Jalpa A, Li Pengxiang, Klebanoff Matthew J, Lin John K

机构信息

Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

出版信息

JAMA Health Forum. 2025 May 2;6(5):e251387. doi: 10.1001/jamahealthforum.2025.1387.

DOI:10.1001/jamahealthforum.2025.1387
PMID:40377932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12084838/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9e9/12084838/e2d84749ae68/jamahealthforum-e251387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9e9/12084838/e2d84749ae68/jamahealthforum-e251387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9e9/12084838/e2d84749ae68/jamahealthforum-e251387-g001.jpg

相似文献

1
Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs.《降低通胀法案》条款与医疗保险D部分特殊药物的自付费用
JAMA Health Forum. 2025 May 2;6(5):e251387. doi: 10.1001/jamahealthforum.2025.1387.
2
Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Risk Factors Under the Inflation Reduction Act.《平价医疗法案下，心血管疾病风险因素的 Medicare 受益人自付药品费用》。
J Am Coll Cardiol. 2023 Apr 18;81(15):1491-1501. doi: 10.1016/j.jacc.2023.02.002. Epub 2023 Feb 20.
3
Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan.根据《降低通胀法案》降低医疗保险D部分专科口服抗癌药物的自付费用：强调加入医疗保险处方药支付计划的益处。
JCO Oncol Pract. 2025 Apr 25:OP2400937. doi: 10.1200/OP-24-00937.
4
Out-of-Pocket Prescription Drug Savings for Medicare Beneficiaries with Asthma and COPD Under the Inflation Reduction Act.《降低通胀法案》下哮喘和慢性阻塞性肺疾病医疗保险受益人的自付处方药节省费用情况
J Gen Intern Med. 2025 Apr;40(5):1141-1149. doi: 10.1007/s11606-024-09063-4. Epub 2024 Oct 4.
5
The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.《降低通胀法案》与心血管疾病 Medicare 受益人的自付药物费用。
J Am Coll Cardiol. 2023 May 30;81(21):2103-2111. doi: 10.1016/j.jacc.2023.03.414.
6
Estimating the Impact of the Inflation Reduction Act on the Out-of-Pocket Costs for Medicare Beneficiaries With Advanced Prostate Cancer.估算《降低通胀法案》对患有晚期前列腺癌的 Medicare 受益人的自付费用的影响。
Urol Pract. 2023 Sep;10(5):476-483. doi: 10.1097/UPJ.0000000000000425. Epub 2023 Jul 3.
7
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.《降低通胀法案》下患有痴呆症的医疗保险受益人的自付药品费用变化：一项模拟研究
Value Health. 2025 Apr;28(4):553-561. doi: 10.1016/j.jval.2025.01.008. Epub 2025 Jan 27.
8
The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?《降低通胀法案》：医疗保险药品价格谈判将如何影响心脏病患者？
Curr Cardiol Rep. 2023 Jun;25(6):577-581. doi: 10.1007/s11886-023-01878-7. Epub 2023 Apr 25.
9
Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.接受受价格谈判约束的处方药的医疗保险受益人在社会人口统计学和支出特征方面的情况。
J Manag Care Spec Pharm. 2024 Mar 1;30(3):269-278. doi: 10.18553/jmcp.2023.23153. Epub 2023 Dec 23.
10
The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes.医疗保险处方药部分对老年糖尿病患者自付处方药费用比例的影响。
Diabetes Care. 2017 Apr;40(4):502-508. doi: 10.2337/dc16-0902. Epub 2016 Nov 1.

引用本文的文献

1
Changes in Medicare Part D Plan Designs After the Inflation Reduction Act.《降低通胀法案》出台后医疗保险D部分计划设计的变化。
JAMA Intern Med. 2025 Aug 18. doi: 10.1001/jamainternmed.2025.4003.

本文引用的文献

1
Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of "too much too soon".在 Medicare Part D 下降低特殊药物使用的自付费用障碍：解决“太多太快”的问题。
Am J Manag Care. 2017 Mar;23(3 Suppl):S39-S45.
2
Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents.患者自付费用与新型口服抗癌药物的处方放弃和延迟配药之间的关联。
J Clin Oncol. 2018 Feb 10;36(5):476-482. doi: 10.1200/JCO.2017.74.5091. Epub 2017 Dec 20.